SBIR-STTR Award

Funding of Phase II SBIR Contract. N44 DA-12-2227
Award last edited on: 1/8/15

Sponsored Program
SBIR
Awarding Agency
NIH : NIDA
Total Award Amount
$1,135,412
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Adam Hanina

Company Information

Ai Cure Technologies Inc (AKA: Aicure LLC)

122 West 27th 10th Floor
New York, NY 10001
   (646) 723-1260
   N/A
   www.aicuretechnologies.com
Location: Single
Congr. District: 12
County: New York

Phase I

Contract Number: 271201200020C-0-0-1
Start Date: 8/15/12    Completed: 2/14/13
Phase I year
2012
Phase I Amount
$137,921
AI Cure Technologies seeks to develop and test the effectiveness and usability of AiView-HR, an automated, population-based medication adherence monitoring system for high-risk, substance abuse populations. AiView-HR will be a significant extension of Ai Cure Technologies' flagship computer-vision product, AiView, incorporating enhanced security sequence elements that will be critical to deploying automated DOT (directly observed therapy) to the high-risk, substance abuse population. Like AiView, AiView-HR will be coupled with a robust web-based dashboard that enables efficient population-based or individual monitoring, review, and intervention of medication adherence.

Project Terms:
Address; Adherence (attribute); Code; Computer software; Computer Vision Systems; Computers; Contractor; Coupled; Detection; Development; Devices; Directly Observed Therapy; Effectiveness; Electronics; Elements; Ensure; Film; Generic Drugs; high risk; Individual; Intervention; medication compliance; Monitor; Online Systems; Oral; Patients; Pharmaceutical Preparations; Phase; phase 1 study; Population; population based; programs; Reporting; Security; Small Business Innovation Research Grant; software systems; Solutions; Substance abuse problem; Subutex; System; Tablets; Techniques; Technology; Testing; Trademark; usability

Phase II

Contract Number: 271201300036C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2013
Phase II Amount
$997,491
Under this Small Business Innovation Research (SBIR) Phase II project, 'Automating Directly Observed Therapy as a Platform Technology,' under Research Topic 139, the Contractor shall provide and evaluate the effectiveness and accuracy of a system for monitoring medication adherence in a treatment setting. In addition to monitoring, an intrinsic component of the system will be an integrated communication platform allowing for intervention and feedback with the user and a measure of the accuracy of the system. Following additional development work on the system, the Contractor will implement the AiView-HR ¿ system in a clinical trial with the objectives of (1) providing a measure of the accuracy of the system, and (2) demonstrating that the system improves medication adherence.

Project Terms:
Clinical Trials Communication; Contractor; Development; Directly Observed Therapy; Effectiveness; Feedback; Funding ;improved; Intervention; Measures; medication compliance; Monitor; Outcome; Pharmaceutical Preparations; Phase; Research; Research Contracts; Small Business Innovation Research Grant; System;Technology; Work;